Exact Mass: 315.08484180000005
Exact Mass Matches: 315.08484180000005
Found 59 metabolites which its exact mass value is equals to given mass value 315.08484180000005,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Chlorprothixene
C18H18ClNS (315.08484180000005)
Chlorprothixene is only found in individuals that have used or taken this drug. It is a typical antipsychotic drug of the thioxanthene (tricyclic) class. Chlorprothixene exerts strong blocking effects by blocking the 5-HT2 D1, D2, D3, histamine H1, muscarinic and alpha1 adrenergic receptors. Chlorprothixene blocks postsynaptic mesolimbic dopaminergic D1 and D2 receptors in the brain; depresses the release of hypothalamic and hypophyseal hormones and is believed to depress the reticular activating system thus affecting basal metabolism, body temperature, wakefulness, vasomotor tone, and emesis. D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AF - Thioxanthene derivatives D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Chlorprothixene is a dopamine and histamine receptors antagonist with Kis of 18 nM, 2.96 nM, 4.56 nM, 9 nM and 3.75 nM for hD1, hD2, hD3, hD5 and hH1 receptors, respectively. Antipsychotic activity[1].
Rosinidin
An anthocyanidin cation consisting of benzopyrylium with hydroxy substituents at positions 3 and 5, a methoxy group at position 7 and a 4-hydroxy-3-methoxyphenyl group at position 2.
N-(3-Chlorophenyl)-6,7-dimethoxyquinazolin-4-amine
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor D000970 - Antineoplastic Agents > D020032 - Tyrphostins D004791 - Enzyme Inhibitors
AG-1478
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor D000970 - Antineoplastic Agents > D020032 - Tyrphostins D004791 - Enzyme Inhibitors
chlorprothixene
C18H18ClNS (315.08484180000005)
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AF - Thioxanthene derivatives D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Chlorprothixene is a dopamine and histamine receptors antagonist with Kis of 18 nM, 2.96 nM, 4.56 nM, 9 nM and 3.75 nM for hD1, hD2, hD3, hD5 and hH1 receptors, respectively. Antipsychotic activity[1].
p-[N-Propyl-N-(2-carboxyethyl)sulfamoyl]benzoic acid
C13H17NO6S (315.07765420000004)
protizinic acid
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
2-quinolin-2-yl-1-[4-(trifluoromethyl)phenyl]ethanone
2-quinolin-2-yl-1-[3-(trifluoromethyl)phenyl]ethanone
Fotemustine
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01A - Alkylating agents > L01AD - Nitrosoureas C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000970 - Antineoplastic Agents
(R)-(-)-n-(3,5-dinitrobenzoyl)-alpha-phenylethylamine
2-[4-(2-pyrimidinyl)-1-piperazinyl]ethanamine(SALTDATA: 3HCl)
C10H20Cl3N5 (315.07842100000005)
ETHYL 2-(4-CHLOROPHENYL)-7-METHYLPYRAZOLO[1,5-A]PYRIMIDINE-6-CARBOXYLATE
6-[Methyl(propyl)amino]-5,6,7,8-tetrahydro-2,3-naphthalenediol hy drobromide (1:1)
ethyl 4-chloro-5-methyl-7-phenylpyrrolo[2,3-d]pyrimidine-6-carboxylate
3-Nitro-4-[[(tetrahydropyran-4-yl)methyl]amino]benzenesulfonamide
C12H17N3O5S (315.08888720000004)
5-METHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRAZOL-3-YL 2-CHLORONICOTINATE
4-Chloro-2-(piperazin-1-yl)-6-(trifluoromethyl)quinoline
(S)-(+)-CROTONYLCYCLOPENTANEDIENYLIRONCARBONYLTRIPHENYLPHOSPHINECOMPLEX
b-Alanine,N-(2-carboxyethyl)-N-[(4-methylphenyl)sulfonyl]-
C13H17NO6S (315.07765420000004)
3-(4-FLUORO-BENZENESULFONYL)-AZETIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
C14H18FNO4S (315.09405200000003)
2-[4-(2-Nitrobenzenesulfonyl)piperazin-1-yl]ethanol
C12H17N3O5S (315.08888720000004)
tert-butyl 2-(2,3-difluoro-6-nitrophenyl)-3-oxobutanoate
Cidofovir Dihydrate
D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C471 - Enzyme Inhibitor > C29575 - DNA Polymerase Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent D004791 - Enzyme Inhibitors
1-(Toluene-4-sulfonyl)-1,2,3,4-tetrahydrobenzo[b]azepin-5-one
4-(4-fluorophenyl)-3-[2-(4-hydroxyphenyl)ethyl]-1H-1,2,4-triazole-5-thione
C16H14FN3OS (315.08415660000003)
1-[(3,4-dimethoxyphenyl)sulfonyl]proline
C13H17NO6S (315.07765420000004)
5H-Benzo(4,5)cyclohepta(1,2-b)naphthalene-5,12-imine-6,11,13(12H)-trione, 14-methyl-
(3E)-3-(2-chloro-9H-thioxanthen-9-ylidene)-N,N-dimethylpropan-1-amine
C18H18ClNS (315.08484180000005)
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants
9-phenyl-3,4a,5,6,7,8,8a,9-octahydro-2H-5,8-methanothiochromeno[2,3-d][1,3]thiazol-2-one
2-{[({1-[2-(4-Methoxyphenyl)cyclopropyl]ethylidene}amino)oxy]carbonyl}thiophene
diethyl [(1S)-1-{[(2-chloroethyl)(nitroso)carbamoyl]amino}ethyl]phosphonate
D000970 - Antineoplastic Agents
(3r)-3-Ethyl-N-[(4-Methylphenyl)sulfonyl]-L-Aspartic Acid
C13H17NO6S (315.07765420000004)
(3R)-3-(2,4-dimethoxyphenyl)-7-hydroxy-4-oxo-2,3-dihydrochromen-5-olate
3-N-[(2-chloro-6-phenoxyphenyl)methyl]-1H-1,2,4-triazole-3,5-diamine
4-(3-methylphenyl)-3-(5-propyl-3-thiophenyl)-1H-1,2,4-triazole-5-thione
4-(3-methylphenyl)-3-(5-propan-2-yl-3-thiophenyl)-1H-1,2,4-triazole-5-thione
N-[(3-methoxybenzoyl)oxy]-4-nitrobenzenecarboximidamide
3-(4-ethyl-5-methyl-3-thiophenyl)-4-(phenylmethyl)-1H-1,2,4-triazole-5-thione
3-[3-(2-Methoxyphenoxy)propyl]-1,3-benzothiazol-2-one
4-(phenylmethyl)-3-(5-propyl-3-thiophenyl)-1H-1,2,4-triazole-5-thione
(2s,3s,4r,5r)-2-{4,6-dihydroxyimidazo[4,5-d][1,2,3]triazin-5-yl}-6-(hydroxymethyl)oxane-3,4,5-triol
C10H13N5O7 (315.08149480000003)
6-hydroxy-3-[(2r,3r,4s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-7h-imidazo[4,5-d][1,2,3]triazin-4-one
C10H13N5O7 (315.08149480000003)
[3,5-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)chromen-7-ylidene](methyl)oxidanium
(2r,3r,4s,5s,6r)-2-{4,6-dihydroxyimidazo[4,5-d][1,2,3]triazin-7-yl}-6-(hydroxymethyl)oxane-3,4,5-triol
C10H13N5O7 (315.08149480000003)